MedicaLink s.r.l., Genova, Italy.
Respir Med. 2009 Jun;103(6):866-72. doi: 10.1016/j.rmed.2008.12.017. Epub 2009 Feb 6.
Spirometry may reveal pre-clinical abnormal airway function in asymptomatic subjects and allow a better definition of severity in clinically diagnosed asthma and COPD. The hypothesis of this study was that telespirometry might increase the diagnostic accuracy of asthma and COPD.
In the Italian "Alliance" study, 638 general practitioners (GPs) were trained to perform telespirometry and were asked to enroll the following categories of subjects: (a) current or ex-smokers without respiratory symptoms; (b) subjects with respiratory symptoms but without a pre-existing diagnosis of asthma or COPD; (c) subjects with a pre-existing clinical diagnosis of asthma; and (d) subjects with a pre-existing clinical diagnosis of COPD. Subjects completed a case report form (CRF) and performed telespirometry in the GP's office. Traces were sent by telephone to a Telespirometry Central Office, where they were interpreted by a pulmonary specialist, according to appropriately defined criteria. The results were returned in real time to the GP.
Overall, 9312 subjects were recruited and 7262 (78%) performed an acceptable telespirometric examination and the CRF. In the asymptomatic group, 340/1437 (24%) of the telespirometries were abnormal (147 with moderate-to-severe airway obstruction, i.e. FEV(1) <80% of predicted). Among symptomatic subjects, 1433/3725 (38%) had abnormal telespirometries (682 with moderate-to-severe obstruction). Of the asthmatic subjects, 336/1285 (26%) had moderate-to-severe airway obstruction, while telespirometry was normal in 184/815 (23%) of the COPD group.
Telespirometry, performed in a GP's office, can aid the diagnosis of obstructive airway diseases and could help GPs to better manage airway obstruction.
在无症状受试者中,肺量测定法可能揭示临床前气道功能异常,并能更好地定义临床诊断的哮喘和 COPD 的严重程度。本研究的假设是远程肺量测定法可能提高哮喘和 COPD 的诊断准确性。
在意大利“Alliance”研究中,638 名全科医生(GP)接受了远程肺量测定法的培训,并被要求招募以下类别的受试者:(a)无呼吸道症状的当前或前吸烟者;(b)有呼吸道症状但无哮喘或 COPD 既往诊断的受试者;(c)有既往临床诊断哮喘的受试者;和(d)有既往临床诊断 COPD 的受试者。受试者填写病例报告表(CRF)并在 GP 办公室进行远程肺量测定。远程肺量测定的轨迹通过电话发送到远程肺量测定中央办公室,由肺科专家根据适当定义的标准进行解释。结果实时返回给 GP。
总体而言,招募了 9312 名受试者,其中 7262 名(78%)进行了可接受的远程肺量测定检查和 CRF。在无症状组中,1437 名中的 340 名(24%)的远程肺量测定结果异常(147 名有中重度气道阻塞,即 FEV1 <80%预计值)。在有症状的受试者中,3725 名中的 1433 名(38%)的远程肺量测定结果异常(682 名有中重度阻塞)。在哮喘患者中,1285 名中有 336 名(26%)有中重度气道阻塞,而在 815 名 COPD 患者中,184 名(23%)的远程肺量测定结果正常。
在 GP 办公室进行的远程肺量测定法可辅助诊断阻塞性气道疾病,并有助于 GP 更好地管理气道阻塞。